331 related articles for article (PubMed ID: 32070274)
1. Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data.
Lopes MB; Vinga S
BMC Bioinformatics; 2020 Feb; 21(1):59. PubMed ID: 32070274
[TBL] [Abstract][Full Text] [Related]
2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.
Darmanis S; Sloan SA; Croote D; Mignardi M; Chernikova S; Samghababi P; Zhang Y; Neff N; Kowarsky M; Caneda C; Li G; Chang SD; Connolly ID; Li Y; Barres BA; Gephart MH; Quake SR
Cell Rep; 2017 Oct; 21(5):1399-1410. PubMed ID: 29091775
[TBL] [Abstract][Full Text] [Related]
4. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.
Wang Q; Tan Y; Fang C; Zhou J; Wang Y; Zhao K; Jin W; Wu Y; Liu X; Liu X; Kang C
Aging (Albany NY); 2019 Sep; 11(18):7707-7722. PubMed ID: 31532757
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
Lai W; Li D; Kuang J; Deng L; Lu Q
Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
[TBL] [Abstract][Full Text] [Related]
7. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.
Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D
Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomics of glioblastoma associates molecular patterns with survival.
Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression.
Pang B; Xu J; Hu J; Guo F; Wan L; Cheng M; Pang L
Mol Oncol; 2019 Dec; 13(12):2588-2603. PubMed ID: 31487431
[TBL] [Abstract][Full Text] [Related]
10. Tumor Heterogeneity and Molecular Characteristics of Glioblastoma Revealed by Single-Cell RNA-Seq Data Analysis.
Yesudhas D; Dharshini SAP; Taguchi YH; Gromiha MM
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327982
[TBL] [Abstract][Full Text] [Related]
11. Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing.
Hernández Martínez A; Madurga R; García-Romero N; Ayuso-Sacido Á
Cancer Lett; 2022 Feb; 527():66-79. PubMed ID: 34902524
[TBL] [Abstract][Full Text] [Related]
12. Identification and Analysis of Glioblastoma Biomarkers Based on Single Cell Sequencing.
Cheng Q; Li J; Fan F; Cao H; Dai ZY; Wang ZY; Feng SS
Front Bioeng Biotechnol; 2020; 8():167. PubMed ID: 32195242
[TBL] [Abstract][Full Text] [Related]
13. Comparison of glioblastoma (GBM) molecular classification methods.
Lee E; Yong RL; Paddison P; Zhu J
Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
[TBL] [Abstract][Full Text] [Related]
14. A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes.
Dusart P; Hallström BM; Renné T; Odeberg J; Uhlén M; Butler LM
Cell Rep; 2019 Nov; 29(6):1690-1706.e4. PubMed ID: 31693905
[TBL] [Abstract][Full Text] [Related]
15. Machine learning applications on intratumoral heterogeneity in glioblastoma using single-cell RNA sequencing data.
Arteaga-Arteaga HB; Candamil-Cortés MS; Breaux B; Guillen-Rondon P; Orozco-Arias S; Tabares-Soto R
Brief Funct Genomics; 2023 Nov; 22(5):428-441. PubMed ID: 37119295
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
[TBL] [Abstract][Full Text] [Related]
17. Kernel Differential Subgraph Analysis to Reveal the Key Period Affecting Glioblastoma.
Xie J; Sun J; Feng J; Yang F; Wang J; Wen T; Nie Q
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32079293
[TBL] [Abstract][Full Text] [Related]
18. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma.
Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y
J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165
[TBL] [Abstract][Full Text] [Related]
19. Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis.
Xiong Z; Yang Q; Li X
CNS Neurosci Ther; 2020 Sep; 26(9):981-989. PubMed ID: 32488994
[TBL] [Abstract][Full Text] [Related]
20. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
